Inter-Bio

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Inter-Bio - overview

Established

2013

Location

Beijing, -, China

Primary Industry

Biotechnology

About

Based in Beijing, China, and established in 2013, Inter-Bio is a biotechnology company that provides biological testing instruments and equipment. It completed the design, development, simple machine, verification, and small-scale production of two-channel surface plasmon resonance detectors from 2014 to 2018. The two-channel surface plasmon resonance detectors break the morphology of the import brands. It participated in drafting the standard of the development and industrialization of multimode conduction microfluidic surface plasmon resonance spectrometers and completed the R&D, and trial of four-channel surface plasmon resonance detectors from 2015 to 2017.


Inter-Bio provides surface plasmon resonance detectors (MI-S200), enzyme standard analyzers (MR-5100), benchtop colloidal gold quantitative detectors (LF-G1800), benchtop colloidal gold quantitative detectors (LF-G3800), protein activity testers, and biological application chips, reagent kits. Those products are used in the fields of pharmaceuticals, labs, and entry inspection and quarantine.


Current Investors

Jintan Capital

Primary Industry

Biotechnology

Sub Industries

Biotechnology, Medical Devices & Equipment, Hardware, Medical Software

Website

www.interbio.com.cn

Verticals

Manufacturing

Company Stage

Early Stage

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.